| 吉西他滨联合奥沙利铂治疗晚期胰腺癌35例 |
| |
| 引用本文： | 潘伟明.吉西他滨联合奥沙利铂治疗晚期胰腺癌35例[J].中国医药导报,2011,8(4):74-75. |
| |
| 作者姓名： | 潘伟明 |
| |
| 作者单位： | 湖南省株洲智成医院,湖南株洲,412000 |
| |
| 摘 要： | 目的：探讨吉西他滨联合奥沙利铂治疗晚期胰腺癌的近期疗效和安全性。方法：2006年3月～2010年3月,我院将经病理组织学证实的70例晚期胰腺癌患者随机分为吉西他滨联合奥沙利铂治疗组（观察组）和单用吉西他滨治疗组（对照组）,各35例。结果：观察组有效26例（74.30%）,临床受益29例（82.90%）,11例（31.40%）生存期超过1年,中位生存期为7.5个月;对照组有效14例（40.00%）,临床受益20例（57.10%）,仅1例（2.86%）生存期超过1年,中位生存期为4.3个月。两组比较差异有统计学意义（P〈0.05）。不良反应主要为白细胞下降及胃肠道反应。结论：吉西他滨联合奥沙利铂治疗晚期胰腺癌的近期疗效优于单用吉西他滨。
|
| 关 键 词： | 胰腺癌 化疗 吉西他滨 奥沙利铂 |
Gemcitabine combined with Oxaliplatin in the treatment of 35 patients with advanced pancreatic cancer |
| |
| PAN Weiming.Gemcitabine combined with Oxaliplatin in the treatment of 35 patients with advanced pancreatic cancer[J].China Medical Herald,2011,8(4):74-75. |
| |
| Authors: | PAN Weiming |
| |
| Institution: | PAN Weiming(Zhicheng Hospital of Zhuzhou City,Hu′nan Province,Zhuzhou 412000,China) |
| |
| Abstract: | Objective: To evaluate the short-term effect and safety of Gemcitabine combined with Oxaliplatin in the treatment of advanced pancreatic cancer.Methods: From March 2006 to March 2010,70 patients with advanced pancreatic cancer admitted in our hospital confirmed by histopathology were randomly divided into Gemcitabine combined with Oxaliplatin treatment group(observation group) and Gemcitabine alone treatment group(control group),with 35 patients in each group.Results: In the observation group,26 patients(74... |
| |
| Keywords: | Pancreatic cancer Chemotherapy Gemcitabine Oxaliplatin |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
